Loading clinical trials...
Loading clinical trials...
Clinical Study of Chemokine Receptor 4 (CXCR4)-Mediated Precision Targeting of 18F for the Diagnosis of Aldosteronism in Primary Aldosteronism
Conditions
Interventions
[18F]AlF-NOTA-pentixather PET/CT
Locations
1
China
Sichuan Academy of Medical Sciences.Sichuan Provincial People's Hospital
Chengdu, Sichuan, China
Start Date
January 7, 2023
Primary Completion Date
January 1, 2024
Completion Date
June 1, 2024
Last Updated
August 8, 2023
NCT07027254
NCT05368090
Lead Sponsor
Sichuan Provincial People's Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions